(Q77668222)
Statements
Treatment of intermediate risk rhabdomyosarcoma and undifferentiated sarcoma with alternating cycles of vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide (English)
C A Arndt
A G Nascimento
G Schroeder
P J Schomberg
S F Sencer
T L Silberman
C L Moertel
J K Tillisch